
Auteur M. DI FORTI
|
Documents disponibles écrits par cet auteur (7)

T. P. FREEMAN ; S. CRAFT ; J. WILSON ; S. STYLIANOU ; M. ELSOHLY ; M. DI FORTI ; M. T. LYNSKEY | 2021
Dans Addiction (Vol.116, n°5, May 2021) Article : PériodiqueBACKGROUND AND AIMS: Cannabis products with high delta-9-tetrahydrocannabinol (THC) concentrations carry an increased risk of addiction and mental health disorders, while it has been suggested that cannabidiol (CBD) may moderate the effects of T[...]
T. SCHOELER ; N. PETROS ; M. DI FORTI ; E. KLAMERUS ; E. FOGLIA ; O. AJNAKINA ; C. GAYER-ANDERSON ; M. COLIZZI ; D. QUATTRONE ; I. BEHLKE ; S. SHETTY ; P. McGUIRE ; A. S. DAVID ; R. MURRAY ; S. BHATTACHARYYA | 2016
Dans Lancet Psychiatry (The) (Vol.3, n°10, October 2016) Article : PériodiqueENGLISH: Background: Although cannabis use after a first episode of psychosis has been associated with relapse, little is known about the determinants of this most preventable risk factor for relapse of psychosis. Here we aimed to study whether[...]
A. MARCONI ; M. DI FORTI ; C. M. LEWIS ; R. M. MURRAY ; E. VASSOS | 2016
Dans Schizophrenia Bulletin (Vol.42, n°5, September 2016) Article : PériodiqueENGLISH: Cannabis use has been reported to induce long-lasting psychotic disorders and a dose-response relationship has been observed. We performed a systematic review of studies that investigate the association between the degree of cannabis c[...]
D. J. POTTER ; K. HAMMOND ; S. TUFFNELL ; C. WALKER ; M. DI FORTI | 2018
Dans Drug Testing and Analysis (Vol.10, n°4, April 2018) Article : PériodiqueIn 2005 and 2008, studies reported that cannabis in England had become dominated by the sinsemilla (unseeded female) form. The average potency (Delta9-tetrahydrocannabinol [THC] content) of this material had doubled over the previous decade. Can[...]
M. DI FORTI ; A. MARCONI ; E. CARRA ; S. FRAIETTA ; A. TROTTA ; M. BONOMO ; F. BIANCONI ; P. GARDNER-SOOD ; J. O'CONNOR ; M. RUSSO ; S. A. STILO ; T. R. MARQUES ; V. MONDELLI ; P. DAZZAN ; C. PARIANTE ; A. S. DAVID ; F. GAUGHRAN ; Z. ATAKAN ; C. IYEGBE ; J. POWELL ; C. MORGAN ; M. LYNSKEY ; R. M. MURRAY | 2015
Dans Lancet Psychiatry (The) (Vol.2, n°3, March 2015) Article : PériodiqueBackground: The risk of individuals having adverse effects from drug use (eg, alcohol) generally depends on the frequency of use and potency of the drug used. We aimed to investigate how frequent use of skunk-like (high-potency) cannabis in sout[...]
M. DI FORTI ; D. QUATTRONE ; T. P. FREEMAN ; G. TRIPOLI ; C. GAYER-ANDERSON ; H. QUIGLEY ; V. RODRIGUEZ ; H. E. JONGSMA ; L. FERRARO ; C. LA CASCIA ; D. LA BARBERA ; I. TARRICONE ; D. BERARDI ; A. SZOKE ; C. ARANGO ; A. TORTELLI ; E. VELTHORST ; M. BERNARDO ; C. M. DEL-BEN ; P. R. MENEZES ; J. P. SELTEN ; P. B. JONES ; J. B. KIRKBRIDE ; B. P. F. RUTTEN ; L. DE HAAN ; P. C. SHAM ; J. VAN OS ; C. M. LEWIS ; M. LYNSKEY ; C. MORGAN ; R. M. MURRAY ; EU-GEI WP2 Group | 2019
Dans Lancet Psychiatry (The) (Vol.6, n°5, May 2019) Article : PériodiqueBackground: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic[...]
R. M. MURRAY ; H. QUIGLEY ; D. QUATTRONE ; A. ENGLUND ; M. DI FORTI | 2016
Dans World Psychiatry (Vol.15, n°3, October 2016) Article : PériodiqueEpidemiological evidence demonstrates that cannabis use is associated with an increased risk of psychotic outcomes, and confirms a dose-response relationship between the level of use and the risk of later psychosis. High-potency cannabis and syn[...]